Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Heart, Vascular and Thoracic

Obstructive hypertrophic cardiomyopathy
November 21, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

REMS Update: Mavacamten Still Effective in Treating Real-World Patients With HCM

Few patients report left ventricular dysfunction or heart failure after one year

cardiac MRI showing obstructive hypertrophic cardiomyopathy
November 20, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

Final VALOR-HCM Report: At 128 Weeks, Mavacamten Sustains Gains in HCM Patients

Avoidance of septal reduction therapy continues while LVEF dysfunction remains infrequent

edge of an apolipoprotein particle
November 19, 2024/Heart, Vascular and Thoracic/Preventive Cardiology

Small-Interfering RNA Shows Cumulative Lp(a) Reduction With Successive Doses

Phase 2 trial of zerlasiran yields first demonstration of longer effect with each dose of an siRNA

medical device deployed in the heart's left atrial appendage
November 18, 2024/Heart, Vascular and Thoracic/Electrophysiology

LAA Occlusion Compares Favorably With Newer Oral Anticoagulants After AF Ablation

OPTION trial demonstrates significantly less bleeding risk with comparable efficacy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

deployment of balloon aortic valvuloplasty device in the heart
November 15, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

Outcomes of Contemporary Therapy for Cardiogenic Shock Due to Severe Aortic Stenosis

Aortic valve replacement is best option for lowering mortality in this high-risk population

occluded pulmonary vein on angiography
November 11, 2024/Heart, Vascular and Thoracic/Interventional Cardiology

Adding Drug-Coated Balloon Angioplasty to Stenting Reduces Pulmonary Vein Restenosis

Novel approach outperforms standard of care for post-PVI stenosis and occlusion

echocardiograms showing heart valve disease
November 8, 2024/Heart, Vascular and Thoracic/Education

Structural Valve Imaging Summit Returns With State-of-the-Art Program, Abundant Expert Interaction

27th offering of this CME favorite to be held March 6-9 in Hollywood, Florida

stylized heart and lungs with text overlay
November 7, 2024/Heart, Vascular and Thoracic/Outcomes

Vitals: Outcomes in Adult Cardiac Surgery and Ischemic and Vascular Disease

A graphical recap of our recent data from some key cardiovascular areas

heller myotomy operation
November 5, 2024/Heart, Vascular and Thoracic/Thoracic Surgery & Lung Transplant

Heller Myotomy for Esophageal Achalasia: 15-Year Freedom From Reintervention Is > 80%

25-year series of over 1,000 patients reveals good long-term palliation, esophageal preservation

Illustration of lungs, liver and kidneys
October 30, 2024/Transplant

Case Report: A Triple-organ Transplant for Comorbidities of Alpha-1 Antitrypsin Deficiency

First-ever procedure restores patient’s health

BackPage 1 of 104Next

Advertisement

Ad